Archive · 17 Sep 2025
Brazil Approves MagicTouch Sirolimus-Coated Balloon for CAD
Imagine tiny balloons that deliver medicine directly to blocked heart arteries.
Brazil has approved a new type of balloon called MagicTouch.
It's coated with medicine that helps prevent arteries from getting blocked again.
This is good news for people with heart problems because it offers a safer alternative to some treatments.
The new balloon doesn't leave any metal behind, which lowers the risk of future problems.
This helps Concept Medical expand and help more people in Latin America.
A doctor in Brazil is excited about the new option, which is backed by lots of research.
ANVISA granted commercial approval for Concept Medical's MagicTouch SCB in Brazil.
MagicTouch is the first and only ANVISA-approved sirolimus-coated balloon in Brazil for CAD.
The approval enables access to treatment across Brazil.
It offers a metal-free alternative to DES, potentially improving long-term outcomes.
Concept Medical aims to expand access to safer treatments in the region.
- Who
- Concept Medical
- What
- ANVISA approved the MagicTouch SCB for CAD treatment.
- When
- September 17, the announcement was made.
- Where
- Brazil
- Why
- To provide a safer, more effective treatment option for CAD patients, expanding access in Latin America.
- Product
- MagicTouch Sirolimus-Coated Balloon (SCB)
- Approval Agency
- ANVISA (Brazil's Health Surveillance Agency)
- Indication
- Coronary Artery Disease (CAD)
- Manufacturer
- Concept Medical
- Benefit
- Metal-free option, reducing restenosis risk
- Location
- Brazil